Redmile Group, LLC Insider Trading
Get the latest insider transactions of Redmile Group, LLC. Redmile Group, LLC is 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in VAPOTHERM INC ($VAPO) and in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in Neoleukin Therapeutics, Inc. ($NLTX) and in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in FATE THERAPEUTICS INC ($FATE) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Atreca, Inc. ($BCEL) and 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Allakos Inc. ($ALLK) and 10% Owner in Stoke Therapeutics, Inc. ($STOK) and Director in Shattuck Labs, Inc. ($STTK) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Gritstone Oncology, Inc. ($GRTS) and 10% Owner in Allovir, Inc. ($ALVR) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in HOOKIPA Pharma Inc. ($HOOK) and 10% Owner in Aprea Therapeutics, Inc. ($APRE) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR). Discover the current value of Redmile Group, LLC shares.
Address: 1 LETTERMAN DRIVE, BLDG D, STE D3-300 SAN FRANCISCO 94129CA
Redmile Group, LLC is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ARRY | ARRAY BIOPHARMA INC | 10% Owner | 16,658,072 | 175,409,498.16 |
FOLD | AMICUS THERAPEUTICS, INC. | 10% Owner | 12,956,446 | 77,997,804.92 |
SYRS | Syros Pharmaceuticals, Inc. | 10% Owner | 84,760 | 925,579.20 |
ALDR | ALDER BIOPHARMACEUTICALS INC | Director | 0 | 0.00 |
XERS | XERIS PHARMACEUTICALS INC | 10% Owner | 3,000,642 | |
ALLK | Allakos Inc. | 10% Owner | 1,009,090 | |
REPL | Replimune Group, Inc. | 10% Owner | 779,655 | |
FATE | FATE THERAPEUTICS INC | Director | 12,957,222 | 36,280,221.60 |
GRTS | Gritstone bio, Inc. | 10% Owner | 869,562 | |
VAPO | VAPOTHERM INC | 10% Owner | 816,683 | |
TCRR | TCR2 THERAPEUTICS INC. | 10% Owner | 807,256 | |
HOOK | HOOKIPA Pharma Inc. | 10% Owner | 999,322 | |
STOK | Stoke Therapeutics, Inc. | 10% Owner | 671,808 | |
AKRO | Akero Therapeutics, Inc. | 10% Owner | 743,802 | |
BCEL | Atreca, Inc. | 10% Owner | 715,306 | |
IGMS | IGM Biosciences, Inc. | Director | 3,426,297 | |
APRE | Aprea Therapeutics, Inc. | 10% Owner | 1,774,581 | |
CABA | Cabaletta Bio, Inc. | 10% Owner | 696,378 | |
BEAM | Beam Therapeutics Inc. | 10% Owner | 1,161,458 | |
NLTX | Neoleukin Therapeutics, Inc. | 10% Owner | 3,916,579 | 73,670,850.99 |
PLRX | PLIANT THERAPEUTICS, INC. | 10% Owner | 1,910,657 | |
RPTX | Repare Therapeutics Inc. | 10% Owner | 1,586,174 | |
NRIX | Nurix Therapeutics, Inc. | 10% Owner | 1,176,470 | |
ANNX | Annexon, Inc. | 10% Owner | 1,596,222 | |
ALVR | Allovir, Inc. | 10% Owner | 823,371 | |
KYMR | Kymera Therapeutics, Inc. | 10% Owner | 1,630,660 | |
STTK | Shattuck Labs, Inc. | Director | 2,178,738 |
Insider Trading Transactions of Redmile Group, LLC
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Option Exercise | 29.34 | 3,434 | 100,754 | 3,434 |
Apr 02 2021 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 0.00 | 130 | 0 | 3,426,297 |
Feb 16 2021 | APRE | Aprea Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Sell | 5.58 | 494,137 | 2,757,284 | 1,774,581 |
Feb 16 2021 | APRE | Aprea Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Sell | 5.80 | 5,863 | 34,005 | 1,768,718 |
Jan 12 2021 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Buy | 85.50 | 327,485 | 27,999,968 | 12,957,222 |
Jan 12 2021 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 0.00 | 257,310 | 257 | 257,310 |
Jan 05 2021 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 0.00 | 178 | 0 | 3,426,167 |
Dec 28 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Option Exercise | 53.02 | 1,286 | 68,184 | 1,286 |
Dec 15 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 0.01 | 667,666 | 6,677 | 667,666 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 0.00 | 2,178,738 | 0 | 2,178,738 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 17.00 | 2,941,176 | 49,999,992 | 5,119,914 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 18.01 | 158,100 | 2,847,666 | 5,278,014 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 19.20 | 195,158 | 3,747,580 | 5,473,172 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 20.00 | 65,047 | 1,300,797 | 5,538,219 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 21.09 | 31,695 | 668,308 | 5,569,914 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Buy | 22.10 | 50,000 | 1,105,000 | 5,619,914 |
Oct 15 2020 | STTK | Shattuck Labs, Inc. | Redmile Group, LLC | Director | Option Exercise | 0.00 | 318,064 | 0 | 0 |
Sep 09 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 50.28 | 74,433 | 3,742,186 | 3,355,438 |
Sep 09 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 49.91 | 47,113 | 2,351,504 | 3,402,551 |
Sep 09 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 52.96 | 14,610 | 773,811 | 3,417,161 |
Sep 09 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 51.85 | 8,650 | 448,523 | 3,425,811 |
Sep 03 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 44.84 | 41,759 | 1,872,327 | 3,186,115 |
Sep 03 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 45.54 | 1,464 | 66,674 | 3,187,579 |
Sep 03 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 46.76 | 19,173 | 896,593 | 3,206,752 |
Sep 03 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 48.69 | 74,253 | 3,615,208 | 3,281,005 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,630,660 | 0 | 1,630,660 |
Aug 25 2020 | KYMR | Kymera Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 2,600,740 | 0 | 0 |
Aug 05 2020 | ALVR | Allovir, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 823,371 | 0 | 823,371 |
Aug 05 2020 | ALVR | Allovir, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,226,993 | 0 | 0 |
Jul 30 2020 | NRIX | Nurix Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,176,470 | 0 | 1,176,470 |
Jul 30 2020 | NRIX | Nurix Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,176,470 | 0 | 0 |
Jul 30 2020 | ANNX | Annexon, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,596,222 | 0 | 1,596,222 |
Jul 30 2020 | ANNX | Annexon, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 14,062,719 | 0 | 0 |
Jul 06 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 0.00 | 178 | 0 | 3,144,356 |
Jun 25 2020 | RPTX | Repare Therapeutics Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,586,174 | 0 | 1,586,174 |
Jun 25 2020 | RPTX | Repare Therapeutics Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,586,174 | 0 | 0 |
Jun 17 2020 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Buy | 28.31 | 1,412,928 | 39,999,992 | 12,629,737 |
Jun 09 2020 | PLRX | PLIANT THERAPEUTICS, INC. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,910,657 | 0 | 1,910,657 |
Jun 09 2020 | PLRX | PLIANT THERAPEUTICS, INC. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 13,661,202 | 0 | 0 |
May 05 2020 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 26.59 | 16,000 | 425,440 | 16,000 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 9.21 | 50,000 | 460,395 | 3,916,579 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 9.91 | 29,800 | 295,169 | 3,946,379 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 10.27 | 2,700 | 27,741 | 3,949,079 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 10.18 | 22,500 | 229,079 | 3,971,579 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 10.71 | 7,500 | 80,309 | 3,979,079 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 10.95 | 33,500 | 366,765 | 4,012,579 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 11.65 | 9,000 | 104,865 | 4,021,579 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Sell | 11.06 | 9,634 | 106,567 | 4,011,945 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Sell | 11.87 | 200 | 2,373 | 4,011,745 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 11.36 | 38,300 | 435,107 | 4,050,045 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Buy | 11.85 | 1,000 | 11,851 | 4,051,045 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Sell | 11.30 | 9,734 | 110,032 | 4,041,311 |
Apr 06 2020 | NLTX | Neoleukin Therapeutics, I ... | Redmile Group, LLC | 10% Owner | Sell | 11.82 | 100 | 1,182 | 4,041,211 |
Apr 03 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 0.00 | 178 | 0 | 3,144,178 |
Apr 03 2020 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 40.27 | 10,000 | 402,700 | 10,000 |
Feb 11 2020 | BEAM | Beam Therapeutics Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,161,458 | 0 | 1,161,458 |
Feb 11 2020 | BEAM | Beam Therapeutics Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 5,208,333 | 0 | 0 |
Oct 29 2019 | CABA | Cabaletta Bio, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 696,378 | 0 | 696,378 |
Oct 29 2019 | CABA | Cabaletta Bio, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,044,568 | 0 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Sell | 0.00 | 8,244,896 | 0 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 0.00 | 779,776 | 0 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 137.88 | 75,000 | 10,341,000 | 75,000 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 137.88 | 75,000 | 10,341,000 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 0.00 | 75,000 | 0 | 75,000 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 188.64 | 54,757 | 10,329,360 | 20,243 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 0.00 | 20,243 | 0 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 13.20 | 30,000 | 396,000 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 15.50 | 15,000 | 232,500 | 0 |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 11.01 | 22,500 | 247,725 | 0 |
Oct 08 2019 | APRE | Aprea Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,868,718 | 0 | 1,868,718 |
Oct 08 2019 | APRE | Aprea Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | 15.00 | 400,000 | 6,000,000 | 2,268,718 |
Oct 08 2019 | APRE | Aprea Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,164,674 | 0 | 0 |
Sep 23 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 16.00 | 3,144,000 | 50,304,000 | 3,144,000 |
Sep 23 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 0.00 | 1,891,530 | 0 | 0 |
Sep 23 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 0.00 | 1,891,530 | 0 | 1,891,530 |
Sep 23 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Buy | 16.00 | 3,144,000 | 50,304,000 | 3,144,000 |
Sep 23 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 0.00 | 1,891,530 | 0 | 0 |
Sep 23 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 0.00 | 1,891,530 | 0 | 1,891,530 |
Sep 19 2019 | IGMS | IGM Biosciences, Inc. | Redmile Group, LLC | Director | Option Exercise | 16.00 | 12,100 | 193,600 | 12,100 |
Sep 17 2019 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Buy | 17.50 | 857,143 | 15,000,003 | 11,216,809 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 0.00 | 25,000 | 0 | 2,794,549 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 0.00 | 25,000 | 0 | 25,000 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 0.00 | 25,000 | 0 | 0 |
Jul 01 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 0.00 | 19,023 | 0 | 779,776 |
Jun 24 2019 | STOK | Stoke Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 671,808 | 0 | 671,808 |
Jun 24 2019 | STOK | Stoke Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 671,808 | 0 | 0 |
Jun 24 2019 | AKRO | Akero Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 743,802 | 0 | 743,802 |
Jun 24 2019 | AKRO | Akero Therapeutics, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 2,286,585 | 0 | 0 |
Jun 24 2019 | BCEL | Atreca, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 715,306 | 0 | 715,306 |
Jun 24 2019 | BCEL | Atreca, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 715,306 | 0 | 0 |
May 24 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 11.01 | 22,500 | 247,725 | 22,500 |
May 06 2019 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 17.15 | 16,000 | 274,400 | 16,000 |
Apr 24 2019 | HOOK | HOOKIPA Pharma Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 999,322 | 0 | 999,322 |
Apr 24 2019 | HOOK | HOOKIPA Pharma Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 85,830 | 0 | 0 |
Mar 06 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Buy | 11.50 | 1,739,130 | 19,999,995 | 8,244,896 |
Feb 21 2019 | XERS | XERIS PHARMACEUTICALS INC | Redmile Group, LLC | 10% Owner | Buy | 10.00 | 588,000 | 5,880,000 | 3,000,642 |
Feb 21 2019 | TCRR | TCR2 THERAPEUTICS INC. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 807,256 | 0 | 807,256 |
Feb 21 2019 | TCRR | TCR2 THERAPEUTICS INC. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 5,000,000 | 0 | 0 |
Jan 03 2019 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 0.00 | 18,558 | 0 | 760,753 |
Nov 16 2018 | VAPO | VAPOTHERM INC | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 816,683 | 0 | 816,683 |
Nov 16 2018 | VAPO | VAPOTHERM INC | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 142,857 | 0 | 959,540 |
Nov 16 2018 | VAPO | VAPOTHERM INC | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 11,433,597 | 0 | 0 |
Nov 16 2018 | VAPO | VAPOTHERM INC | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,759,015 | 0 | 0 |
Oct 03 2018 | GRTS | Gritstone Oncology, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 869,562 | 0 | 869,562 |
Oct 03 2018 | GRTS | Gritstone Oncology, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 371,607 | 0 | 1,241,169 |
Oct 03 2018 | GRTS | Gritstone Oncology, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 153,360 | 0 | 1,394,529 |
Oct 03 2018 | GRTS | Gritstone Oncology, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 869,562 | 0 | 0 |
Oct 03 2018 | GRTS | Gritstone Oncology, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 371,607 | 0 | 0 |
Oct 03 2018 | GRTS | Gritstone Oncology, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 153,360 | 0 | 0 |
Sep 27 2018 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Buy | 13.50 | 3,703,704 | 50,000,004 | 10,359,666 |
Aug 02 2018 | FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Option Exercise | 8.93 | 24,000 | 214,320 | 24,000 |
Jul 25 2018 | REPL | Replimune Group, Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 779,655 | 0 | 779,655 |
Jul 25 2018 | REPL | Replimune Group, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 78,382 | 0 | 0 |
Jul 24 2018 | ALLK | Allakos Inc. | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 1,009,090 | 0 | 1,009,090 |
Jul 24 2018 | ALLK | Allakos Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 1,261,365 | 0 | 0 |
Jul 18 2018 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 0.00 | 16,927 | 0 | 742,195 |
Jun 27 2018 | XERS | XERIS PHARMACEUTICALS INC | Redmile Group, LLC | Buy | 0.00 | 1,745,974 | 0 | 1,745,974 | |
Jun 27 2018 | XERS | XERIS PHARMACEUTICALS INC | Redmile Group, LLC | Buy | 15.00 | 666,668 | 10,000,020 | 2,412,642 | |
Jun 27 2018 | XERS | XERIS PHARMACEUTICALS INC | Redmile Group, LLC | Option Exercise | 0.00 | 3,109,796 | 0 | 0 | |
May 25 2018 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Option Exercise | 15.50 | 15,000 | 232,500 | 15,000 | |
Apr 26 2018 | ALDR | ALDER BIOPHARMACEUTICALS ... | Redmile Group, LLC | Director | Option Exercise | 13.20 | 30,000 | 396,000 | 30,000 |
Sep 30 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Sell | 6.36 | 2,492,578 | 15,852,796 | 16,658,072 |
Sep 16 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Sell | 3.50 | 392,700 | 1,374,450 | 18,757,950 |
Sep 16 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.51 | 372,000 | 1,305,720 | 19,129,950 |
Sep 16 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Sell | 3.54 | 7,300 | 25,842 | 19,122,650 |
Sep 16 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.50 | 28,000 | 98,000 | 19,150,650 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 84,760 | 0 | 84,760 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 47,486 | 0 | 47,486 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 262,069 | 0 | 262,069 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 31,447 | 0 | 31,447 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 0.00 | 40,420 | 0 | 40,420 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 12.50 | 144,383 | 1,804,788 | 191,869 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 12.50 | 104,670 | 1,308,375 | 366,739 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 12.50 | 174,320 | 2,179,000 | 205,767 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Buy | 12.50 | 9,373 | 117,163 | 49,793 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 317,853 | 0 | 0 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 178,074 | 0 | 0 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 982,762 | 0 | 0 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 117,931 | 0 | 0 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Redmile Group, LLC | 10% Owner | Option Exercise | 0.00 | 151,576 | 0 | 0 |
Jun 13 2016 | FOLD | AMICUS THERAPEUTICS INC | Redmile Group, LLC | 10% Owner | Buy | 7.20 | 66,300 | 477,360 | 12,956,446 |
Jan 22 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.19 | 300,000 | 957,000 | 19,150,650 |
Jan 14 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.60 | 75,000 | 270,000 | 18,850,650 |
Jan 11 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.73 | 300,000 | 1,119,000 | 18,150,650 |
Jan 11 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.72 | 350,000 | 1,302,000 | 18,500,650 |
Jan 11 2016 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 3.54 | 275,000 | 973,500 | 18,775,650 |
Oct 01 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 4.56 | 500,000 | 2,280,000 | 17,750,510 |
Oct 01 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 4.67 | 182,452 | 852,051 | 17,932,962 |
Oct 01 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 4.50 | 100,140 | 450,630 | 18,033,102 |
Aug 28 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.48 | 49,900 | 273,452 | 17,250,510 |
Aug 25 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.45 | 160,000 | 872,000 | 16,570,610 |
Aug 25 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.32 | 410,000 | 2,181,200 | 16,980,610 |
Aug 25 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.45 | 220,000 | 1,199,000 | 17,200,610 |
Aug 13 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.85 | 327,500 | 1,915,875 | 16,205,610 |
Aug 13 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.93 | 205,000 | 1,215,650 | 16,410,610 |
Aug 10 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.85 | 592,450 | 3,465,833 | 15,421,567 |
Aug 10 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.67 | 276,543 | 1,567,999 | 15,698,110 |
Aug 10 2015 | ARRY | ARRAY BIOPHARMA INC | Redmile Group, LLC | 10% Owner | Buy | 5.81 | 180,000 | 1,045,800 | 15,878,110 |